Homocysteine levels in adolescent schizophrenia patients

Homocysteine is a sulfur containing amino acid that has been widely investigated for its putative role in cardiovascular and neuropsychiatric disorders. It has been suggested that homocysteine has implications especially in young, male schizophrenia patients. In this prospective case-control study,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European neuropsychopharmacology 2006-12, Vol.16 (8), p.588-591
Hauptverfasser: Nevo, G. Adler, Meged, S., Sela, B.A., Hanoch-Levi, A., Hershko, R., Weizman, A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 591
container_issue 8
container_start_page 588
container_title European neuropsychopharmacology
container_volume 16
creator Nevo, G. Adler
Meged, S.
Sela, B.A.
Hanoch-Levi, A.
Hershko, R.
Weizman, A.
description Homocysteine is a sulfur containing amino acid that has been widely investigated for its putative role in cardiovascular and neuropsychiatric disorders. It has been suggested that homocysteine has implications especially in young, male schizophrenia patients. In this prospective case-control study, we compared plasma homocysteine levels in a group of adolescent schizophrenia inpatients (aged 14–21 years; n=23) to normal healthy controls (n=51). Mean plasma homocysteine levels were significantly higher in the patient group than in the control group (15.40±2.00 and 9.78±0.33 μmol/L, respectively, p
doi_str_mv 10.1016/j.euroneuro.2006.03.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68161836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0924977X06000538</els_id><sourcerecordid>68161836</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-34e511c1d21933417b7b1e78bf102e529e2016b17e5c290a0988a7621bdbcc403</originalsourceid><addsrcrecordid>eNqFkF9LwzAUxYMobk6_gvbJt9bcpE2axzHUCQNfFHwLbXrHMtpmJu1AP70ZG_royz1wOef--RFyBzQDCuJhm-HoXX8oGaNUZJRnUc7IFErJU1kKdk6mVLE8VVJ-TMhVCFtKoeBcXZIJCJFLlqspKZeuc-YrDGh7TFrcYxsS2ydV41oMBvshCWZjv91u47G3VbKrBhu74ZpcrKs24M1JZ-T96fFtsUxXr88vi_kqNVyoIeU5FgAGGgaK8xxkLWtAWdZroAwLppDFf2qQWBimaEVVWVZSMKib2pic8hm5P87defc5Yhh0Z-NdbVv16MagRQkCSi6iUR6NxrsQPK71ztuu8l8aqD5A01v9C00foGnKdZSYvD2tGOsOm7_ciVI0zI-GCAf3Fr0OJkIw2FiPZtCNs_8u-QFMQoJS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68161836</pqid></control><display><type>article</type><title>Homocysteine levels in adolescent schizophrenia patients</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Nevo, G. Adler ; Meged, S. ; Sela, B.A. ; Hanoch-Levi, A. ; Hershko, R. ; Weizman, A.</creator><creatorcontrib>Nevo, G. Adler ; Meged, S. ; Sela, B.A. ; Hanoch-Levi, A. ; Hershko, R. ; Weizman, A.</creatorcontrib><description>Homocysteine is a sulfur containing amino acid that has been widely investigated for its putative role in cardiovascular and neuropsychiatric disorders. It has been suggested that homocysteine has implications especially in young, male schizophrenia patients. In this prospective case-control study, we compared plasma homocysteine levels in a group of adolescent schizophrenia inpatients (aged 14–21 years; n=23) to normal healthy controls (n=51). Mean plasma homocysteine levels were significantly higher in the patient group than in the control group (15.40±2.00 and 9.78±0.33 μmol/L, respectively, p&lt;0.032). The difference was almost entirely attributable to the male schizophrenia subgroup (18.18±5.65 in male patients vs. 10.31±5.33 μmol/L in female patients). The group×sex interaction was statistically significant (p=0.0035). These data indicate that a subgroup of male adolescent schizophrenia patients has high homocysteine blood levels. The role of homocysteine in the pathophysiology of adolescent-onset schizophrenia merits further investigation.</description><identifier>ISSN: 0924-977X</identifier><identifier>EISSN: 1873-7862</identifier><identifier>DOI: 10.1016/j.euroneuro.2006.03.006</identifier><identifier>PMID: 16647249</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adolescent ; Adolescents ; Adult ; Analysis of Variance ; Case-Control Studies ; Chromatography, High Pressure Liquid - methods ; Female ; Homocysteine ; Homocysteine - blood ; Humans ; Male ; Neurodevelopment ; Prospective Studies ; Psychosis ; Schizophrenia ; Schizophrenia - blood</subject><ispartof>European neuropsychopharmacology, 2006-12, Vol.16 (8), p.588-591</ispartof><rights>2006 Elsevier B.V. and ECNP</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-34e511c1d21933417b7b1e78bf102e529e2016b17e5c290a0988a7621bdbcc403</citedby><cites>FETCH-LOGICAL-c369t-34e511c1d21933417b7b1e78bf102e529e2016b17e5c290a0988a7621bdbcc403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.euroneuro.2006.03.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16647249$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nevo, G. Adler</creatorcontrib><creatorcontrib>Meged, S.</creatorcontrib><creatorcontrib>Sela, B.A.</creatorcontrib><creatorcontrib>Hanoch-Levi, A.</creatorcontrib><creatorcontrib>Hershko, R.</creatorcontrib><creatorcontrib>Weizman, A.</creatorcontrib><title>Homocysteine levels in adolescent schizophrenia patients</title><title>European neuropsychopharmacology</title><addtitle>Eur Neuropsychopharmacol</addtitle><description>Homocysteine is a sulfur containing amino acid that has been widely investigated for its putative role in cardiovascular and neuropsychiatric disorders. It has been suggested that homocysteine has implications especially in young, male schizophrenia patients. In this prospective case-control study, we compared plasma homocysteine levels in a group of adolescent schizophrenia inpatients (aged 14–21 years; n=23) to normal healthy controls (n=51). Mean plasma homocysteine levels were significantly higher in the patient group than in the control group (15.40±2.00 and 9.78±0.33 μmol/L, respectively, p&lt;0.032). The difference was almost entirely attributable to the male schizophrenia subgroup (18.18±5.65 in male patients vs. 10.31±5.33 μmol/L in female patients). The group×sex interaction was statistically significant (p=0.0035). These data indicate that a subgroup of male adolescent schizophrenia patients has high homocysteine blood levels. The role of homocysteine in the pathophysiology of adolescent-onset schizophrenia merits further investigation.</description><subject>Adolescent</subject><subject>Adolescents</subject><subject>Adult</subject><subject>Analysis of Variance</subject><subject>Case-Control Studies</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Female</subject><subject>Homocysteine</subject><subject>Homocysteine - blood</subject><subject>Humans</subject><subject>Male</subject><subject>Neurodevelopment</subject><subject>Prospective Studies</subject><subject>Psychosis</subject><subject>Schizophrenia</subject><subject>Schizophrenia - blood</subject><issn>0924-977X</issn><issn>1873-7862</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF9LwzAUxYMobk6_gvbJt9bcpE2axzHUCQNfFHwLbXrHMtpmJu1AP70ZG_royz1wOef--RFyBzQDCuJhm-HoXX8oGaNUZJRnUc7IFErJU1kKdk6mVLE8VVJ-TMhVCFtKoeBcXZIJCJFLlqspKZeuc-YrDGh7TFrcYxsS2ydV41oMBvshCWZjv91u47G3VbKrBhu74ZpcrKs24M1JZ-T96fFtsUxXr88vi_kqNVyoIeU5FgAGGgaK8xxkLWtAWdZroAwLppDFf2qQWBimaEVVWVZSMKib2pic8hm5P87defc5Yhh0Z-NdbVv16MagRQkCSi6iUR6NxrsQPK71ztuu8l8aqD5A01v9C00foGnKdZSYvD2tGOsOm7_ciVI0zI-GCAf3Fr0OJkIw2FiPZtCNs_8u-QFMQoJS</recordid><startdate>200612</startdate><enddate>200612</enddate><creator>Nevo, G. Adler</creator><creator>Meged, S.</creator><creator>Sela, B.A.</creator><creator>Hanoch-Levi, A.</creator><creator>Hershko, R.</creator><creator>Weizman, A.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200612</creationdate><title>Homocysteine levels in adolescent schizophrenia patients</title><author>Nevo, G. Adler ; Meged, S. ; Sela, B.A. ; Hanoch-Levi, A. ; Hershko, R. ; Weizman, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-34e511c1d21933417b7b1e78bf102e529e2016b17e5c290a0988a7621bdbcc403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adolescents</topic><topic>Adult</topic><topic>Analysis of Variance</topic><topic>Case-Control Studies</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Female</topic><topic>Homocysteine</topic><topic>Homocysteine - blood</topic><topic>Humans</topic><topic>Male</topic><topic>Neurodevelopment</topic><topic>Prospective Studies</topic><topic>Psychosis</topic><topic>Schizophrenia</topic><topic>Schizophrenia - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nevo, G. Adler</creatorcontrib><creatorcontrib>Meged, S.</creatorcontrib><creatorcontrib>Sela, B.A.</creatorcontrib><creatorcontrib>Hanoch-Levi, A.</creatorcontrib><creatorcontrib>Hershko, R.</creatorcontrib><creatorcontrib>Weizman, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nevo, G. Adler</au><au>Meged, S.</au><au>Sela, B.A.</au><au>Hanoch-Levi, A.</au><au>Hershko, R.</au><au>Weizman, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homocysteine levels in adolescent schizophrenia patients</atitle><jtitle>European neuropsychopharmacology</jtitle><addtitle>Eur Neuropsychopharmacol</addtitle><date>2006-12</date><risdate>2006</risdate><volume>16</volume><issue>8</issue><spage>588</spage><epage>591</epage><pages>588-591</pages><issn>0924-977X</issn><eissn>1873-7862</eissn><abstract>Homocysteine is a sulfur containing amino acid that has been widely investigated for its putative role in cardiovascular and neuropsychiatric disorders. It has been suggested that homocysteine has implications especially in young, male schizophrenia patients. In this prospective case-control study, we compared plasma homocysteine levels in a group of adolescent schizophrenia inpatients (aged 14–21 years; n=23) to normal healthy controls (n=51). Mean plasma homocysteine levels were significantly higher in the patient group than in the control group (15.40±2.00 and 9.78±0.33 μmol/L, respectively, p&lt;0.032). The difference was almost entirely attributable to the male schizophrenia subgroup (18.18±5.65 in male patients vs. 10.31±5.33 μmol/L in female patients). The group×sex interaction was statistically significant (p=0.0035). These data indicate that a subgroup of male adolescent schizophrenia patients has high homocysteine blood levels. The role of homocysteine in the pathophysiology of adolescent-onset schizophrenia merits further investigation.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>16647249</pmid><doi>10.1016/j.euroneuro.2006.03.006</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0924-977X
ispartof European neuropsychopharmacology, 2006-12, Vol.16 (8), p.588-591
issn 0924-977X
1873-7862
language eng
recordid cdi_proquest_miscellaneous_68161836
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adolescent
Adolescents
Adult
Analysis of Variance
Case-Control Studies
Chromatography, High Pressure Liquid - methods
Female
Homocysteine
Homocysteine - blood
Humans
Male
Neurodevelopment
Prospective Studies
Psychosis
Schizophrenia
Schizophrenia - blood
title Homocysteine levels in adolescent schizophrenia patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A41%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homocysteine%20levels%20in%20adolescent%20schizophrenia%20patients&rft.jtitle=European%20neuropsychopharmacology&rft.au=Nevo,%20G.%20Adler&rft.date=2006-12&rft.volume=16&rft.issue=8&rft.spage=588&rft.epage=591&rft.pages=588-591&rft.issn=0924-977X&rft.eissn=1873-7862&rft_id=info:doi/10.1016/j.euroneuro.2006.03.006&rft_dat=%3Cproquest_cross%3E68161836%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68161836&rft_id=info:pmid/16647249&rft_els_id=S0924977X06000538&rfr_iscdi=true